PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1984 March; 77(3): 172–175.
PMCID: PMC1439859

Hormonal aspects of ovarian malignancy.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (671K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bollen EC, Lamers CB, Jansen JB, Larsson LI, Joosten HJ. Zollinger-Ellison syndrome due to a gastrin-producing ovarian cystadenocarcinoma. Br J Surg. 1981 Nov;68(11):776–777. [PubMed]
  • BUELL P, DUNN JE., Jr CANCER MORTALITY AMONG JAPANESE ISSEI AND NISEI OF CALIFORNIA. Cancer. 1965 May;18:656–664. [PubMed]
  • Darwish DH. The effect of sex steroids on the in vitro synthesis of DNA by malignant ovarian tumours. Br J Obstet Gynaecol. 1978 Aug;85(8):627–633. [PubMed]
  • Davy M, Torjesen PA, Aakavaag A. Demonstration of an FSH receptor in a functioning granulosa cell tumour. The effect of gonadotrophin treatment on its viability following transplantation to nude mice. Acta Endocrinol (Copenh) 1977 Jul;85(3):615–623. [PubMed]
  • Freeman DA, Ascoli M. Desensitization to gonadotropins in cultured Leydig tumor cells involves loss of gonadotropin receptors and decreased capacity for steroidogenesis. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6309–6313. [PubMed]
  • Givens JR, Andersen RN, Wiser WL, Donelson AJ, Coleman SA. A testosterone-secreting, gonadotropin-responsive pure thecoma and polycystic ovarian disease. J Clin Endocrinol Metab. 1975 Nov;41(5):845–853. [PubMed]
  • Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst. 1968 Jan;40(1):43–68. [PubMed]
  • Hamilton TC, Davies P, Griffiths K. Androgen and oestrogen binding in cytosols of human ovarian tumours. J Endocrinol. 1981 Sep;90(3):421–431. [PubMed]
  • Heinonen PK, Tuimala R, Pyykkö K, Pystynen P. Peripheral venous concentrations of oestrogens in postmenopausal women with ovarian cancer. Br J Obstet Gynaecol. 1982 Jan;89(1):84–86. [PubMed]
  • Holt JA, Caputo TA, Kelly KM, Greenwald P, Chorost S. Estrogen and progestin binding in cytosols of ovarian adenocarcinomas. Obstet Gynecol. 1979 Jan;53(1):50–58. [PubMed]
  • Julian CG, Woodruff JD. The role of chemotherapy in the treatment of primary ovarian malignancy. Obstet Gynecol Surv. 1969 Nov;24(11):1307–1342. [PubMed]
  • Kammerman S, Demopoulos RI, Raphael C, Ross J. Gonadotropic hormone binding to human ovarian tumors. Hum Pathol. 1981 Oct;12(10):886–890. [PubMed]
  • Lamberts SW, Timmers JM, Oosterom R, Verleun T, de Jong FH. Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist. J Clin Endocrinol Metab. 1982 Feb;54(2):450–454. [PubMed]
  • Lingeman CH. Etiology of cancer of the human ovary: a review. J Natl Cancer Inst. 1974 Dec;53(6):1603–1618. [PubMed]
  • LONG RT, EVANS AM. DIETHYLSTILBESTROL AS A CHEMOTHERAPEUTIC AGENT FOR OVARIAN CARCINOMA. Mo Med. 1963 Dec;60:1125–1127. [PubMed]
  • Mandel FP, Voet RL, Weiland AJ, Judd HL. Steroid secretion by masculinizing and "feminizing" Hilus cell tumors. J Clin Endocrinol Metab. 1981 Apr;52(4):779–784. [PubMed]
  • Myers AM, Moore GE, Major FJ. Advanced ovarian carcinoma: response to antiestrogen therapy. Cancer. 1981 Dec 1;48(11):2368–2370. [PubMed]
  • Newhouse ML, Pearson RM, Fullerton JM, Boesen EA, Shannon HS. A case control study of carcinoma of the ovary. Br J Prev Soc Med. 1977 Sep;31(3):148–153. [PMC free article] [PubMed]
  • Rome RM, Fortune DW, Quinn MA, Brown JB. Functioning ovarian tumors in postmenopausal women. Obstet Gynecol. 1981 Jun;57(6):705–710. [PubMed]
  • Slayton RE, Pagano M, Creech RH. Progestin therapy for advanced ovarian cancer: a phase II Eastern Cooperative Oncology Group trial. Cancer Treat Rep. 1981 Sep-Oct;65(9-10):895–896. [PubMed]
  • Tobias JS, Griffiths CT. Management of ovarian carcinoma. Current concepts and future prospects. N Engl J Med. 1976 Apr 15;294(16):877–882. [PubMed]
  • Weiss NS, Lyon JL, Krishnamurthy S, Dietert SE, Liff JM, Daling JR. Noncontraceptive estrogen use and the occurrence of ovarian cancer. J Natl Cancer Inst. 1982 Jan;68(1):95–98. [PubMed]
  • Ylikorkala O, Kauppila A, Rajala T. Pituitary gonadotrophins and prolactin in patients with endometrial cancer, fibroids or ovarian tumours. Br J Obstet Gynaecol. 1979 Nov;86(11):901–904. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press